Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A
2013 · Blood · 214 citations
https://doi.org/10.1182/blood-2013-02-483263
A
Alice S. van Velzen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
27
Papers
678
Citations
12
h-index
13
i10-index
Alice S. van Velzen is an academic researcher from Emma Kinderziekenhuis. The author has contributed to research in topics: Hemophilia Treatment and Research & Platelet Disorders and Treatments & Myeloproliferative Neoplasms: Diagnosis and Treatment. The author has an h-index of 12, co-authored 23 publications.
Papers by this author
worksInhibitor development and mortality in non‐severe hemophilia A
2015 · Journal of Thrombosis and Haemostasis · 74 citations
https://doi.org/10.1111/jth.12990
Inhibitor development and mortality in non‐severe hemophilia A
2015 · Journal of Thrombosis and Haemostasis · 74 citations
https://doi.org/10.1111/jth.12990
Desmopressin in moderate hemophilia A patients: a treatment worth considering
2018 · Haematologica · 32 citations
https://doi.org/10.3324/haematol.2017.180059
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat